Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Toray Industries, Inc
Eli Lilly and Company
Emory University
Xennials Therapeutics Australia Pty Ltd
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
University of Southampton
M.D. Anderson Cancer Center